Håvard Midgard (H Midgard)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Hepatitis C Virus

Top Venues

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Kristian Braathen Malme, Kathrine Stene-Johansen, Ingvild Klundby, Øystein Backe, Tarjei Foshaug, Maria Helseth Greve, Charlotte Meinich Pihl, Ane-Kristine Finbråten, Olav Dalgard, Håvard Midgard
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. Viruses 16 (6) (2024)
Kristian Braathen Malme, Kathrine Stene-Johansen, Ingvild Klundby, Øystein Backe, Tarjei Foshaug, Maria Helseth Greve, Charlotte Meinich Pihl, Ane-Kristine Finbråten, Olav Dalgard, Håvard Midgard
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. Viruses 16 (6) (2024)
Håvard Midgard, Kristian B Malme, Ane-Kristine Finbråten, Olav Dalgard
Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Kristian Braathen Malme, Kathrine Stene-Johansen, Ingvild Klundby, Øystein Backe, Tarjei Foshaug, Maria Helseth Greve, Charlotte Meinich Pihl, Ane-Kristine Finbråten, Olav Dalgard, Håvard Midgard
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. Viruses 16 (6) (2024)
Håvard Midgard, Kristian Braathen Malme, Charlotte Meinich Pihl, Riikka Mari Berg-Pedersen, Lars Tanum, Ingvild Klundby, Anne Haug, Ida Tveter, Ronny Bjørnestad, Inge Christoffer Olsen, Ane-Kristine Finbråten, Olav Dalgard
Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Håvard Midgard, Ronny Bjørnestad, Maren Egeland, Eivin Dahl, Ane-Kristine Finbråten, Knut B Kielland, Martin Blindheim, Olav Dalgard
Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs. Liver international : official journal of the International Association for the Study of the Liver 42 (6) (2022)
Lars Thore Fadnes, Christer Frode Aas, Jørn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Ondrasova Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, null null
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS medicine 18 (6) (2021)
Håvard Midgard, A K Finbråten, K B Malme, R M Berg-Pedersen, L Tanum, I C Olsen, R Bjørnestad, O Dalgard
Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs. Trials 21 (1) (2020)
Håvard Midgard, Jørgen G Bramness, Svetlana Skurtveit, John W Haukeland, Olav Dalgard
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study. PloS one 11 (11) (2016)